Posts

Posted on

Army Selects AV’s VAPOR® CLE for Medium Range Reconnaissance Program

Army Selects AV’s VAPOR® CLE for Medium Range Reconnaissance Program

 

ARLINGTON, Va.–(BUSINESS WIRE)–
AeroVironment, Inc. (“AV”) (NASDAQ: AVAV), a global defense technology leader, today announced it was awarded a $14.6 million production contract by the U.S. Army for the VAPOR® Compact Long Endurance (CLE) unmanned aircraft system (UAS), its all-electric vertical takeoff and landing (VTOL) platform, under the Company-Level Directed Requirement (CoLvl DR) Small Uncrewed Aircraft System (SUAS), Tranche 2.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260416053128/en/

AV’s VAPOR® Compact Long Endurance (CLE) unmanned aircraft system—an all-electric VTOL platform – was selected for the Army’s Medium Range Reconnaissance program. (Photo AV)

AV’s VAPOR® Compact Long Endurance (CLE) unmanned aircraft system—an all-electric VTOL platform – was selected for the Army’s Medium Range Reconnaissance program. (Photo AV)

The award supports the Army’s Medium Range Reconnaissance (MRR) initiative, one of the Army’s ongoing unmanned systems procurements.

“Being selected for the Company-Level Directed Requirement validates VAPOR CLE’s performance, adaptability, and mission value,” said Jason Hendrix, Vice President and General Manager of SUAS at AV. “This award reflects AV’s commitment to delivering operationally relevant, rapidly deployable solutions that meet the Army’s urgent needs and evolving mission requirements.”

The Army’s CoLvl DR effort delivers commercially available SUAS capabilities to Brigade Combat Teams (BCTs) to meet immediate operational needs, emphasizing UAS as a complete system. This approach enables modular, reconfigurable, and attritable payloads for reconnaissance, surveillance, and target acquisition, while enhancing adaptability, operational effectiveness, and soldier-driven experimentation to shape future requirements.

Engineered for demanding missions, the VAPOR CLE all-electric helicopter UAS sets a new standard for endurance, payload capacity, and field adaptability. Designed for operations across austere environments — from Arctic terrain to contested maritime conditions — the platform combines rugged reliability with a compact, deploy-anywhere design. Its modular open architecture and multi-sensor payload bay make it one of the most versatile small VTOL systems available.

Its folding airframe and compact pack-out system enable case-to-flight in as little as two minutes, delivering exceptional portability and speed to launch. Ruggedized for extreme weather and harsh sea states, VAPOR CLE can carry up to 24 pounds of payload or lethal munitions and deliver up to two hours of endurance, outperforming other all-electric quadcopters and competing helicopter UAS platforms in its class.

About AV

AeroVironment (“AV”) (NASDAQ: AVAV) is a defense technology leader delivering integrated capabilities across air, land, sea, space, and cyber. The Company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities—built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo™, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. For more information, visit www.avinc.com.

Safe Harbor Statement

Certain statements in this press release may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, forecasts, and assumptions that involve risks and uncertainties, which could cause actual results to differ materially. Factors that may cause such differences include, but are not limited to, our ability to perform under existing contracts and obtain new ones; regulatory changes; competitor activities; market growth; product development challenges; and general economic conditions. For a more detailed discussion of these risks, please refer to AeroVironment’s filings with the Securities and Exchange Commission. We undertake no obligation to update forward-looking statements as a result of new information or future events.

Media Contact:

BJ Koubaroulis

[email protected]

747.324.5358

Investor Contact:

Denise Pacioni

[email protected]

805.795.4108

KEYWORDS: Virginia United States North America Canada

INDUSTRY KEYWORDS: Software EV/Electric Vehicles Other Defense Contracts Alternative Vehicles/Fuels Transportation Technology Automotive Defense Travel Homeland Security Military Public Policy/Government

MEDIA:

Photo
Photo
AV’s VAPOR® Compact Long Endurance (CLE) unmanned aircraft system—an all-electric VTOL platform – was selected for the Army’s Medium Range Reconnaissance program. (Photo AV)
Logo
Logo
Posted on

Nayax at the NAMA Show 2026: Turning Payment Complexity into a Competitive Edge

HERZLIYA, Israel, April 20, 2026 (GLOBE NEWSWIRE) — Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement, payments, and loyalty platform designed to help merchants scale their business, today announced its participation as both exhibitor and sponsor at the NAMA Show 2026 – the industry’s largest annual conference for vending and convenience service professionals – taking place April 22-24, 2026 in Los Angeles, CA.

The NAMA Show is the premier gathering for unattended retail operators across North America. This year Nayax will be at Booth #1929 with a clear message: complexity in unattended retail can be turned into a strength with the right partner.

Nayax delivers an integrated, end-to-end platform designed around how operators run their business. That means the freedom to deploy the right solution at every location, the intelligence to act on real-time data, and the tools to build lasting customer relationships – all through a single partner.

Nayax supports the full spectrum of unattended retail payments- including traditional vending, smart coolers, and micro markets – matching the right technology to each point of sale. The right payment infrastructure goes far beyond authorization rates; it means continuous transaction optimization and ongoing compliance (PCI-DSS, EMV, SOC2, KYC, cash discounting), so operators have full assurance that every transaction that should succeed, does.

As the payments and commerce landscape grows more complex across technology, regulation, and shifting consumer expectations, Nayax has made a deliberate move to embed value-added services such as integrated loyalty, embedded banking, and smart operational tools to enable profitability and competitiveness for Nayax customers.

Nayax will highlight two platform expansions coming in Q2 2026:

  • Embedded Finance: Nayax is expanding further into embedded finance, bringing financial services directly into the commerce platform.
    Coming soon: Yellow Account – a dedicated business account built specifically for small and growing operators, designed to simplify financial management and put real-time financial tools within reach for businesses of every size.
  • Smart operational tools: Nayax’s mobile management app, MoMa, is introducing a new intelligence layer in Q2 2026. Providing operators with access to insights across their business through a conversational assistant, optimization of product placement with planogram suggestions and rapid planogram setup using visual recognition. All building on deep foundation of existing smart capabilities, together helping operators know what matters and act on it.
  • Beyond MoMa, Nayax’s Management Suite and telemetry platform provide operators of any size with full visibility and control over their business. From MoMa and Core to VendCore Pro (formerly VendSYS), its enterprise-grade Vending Management System (VMS), Nayax enables warehousing, forecasting, and route optimization at scale. Whether managing five machines or over fifty thousand, operators have the right tools to streamline operations and accelerate growth.

“As part of Nayax’s commitment to enabling merchants to grow their business at scale and with ease, we are continuously expanding our end-to-end unattended payments platform,” said Carly Furman, CEO of Nayax LLC. “Innovations like the new MoMa AI layer and expanded VMS APIs and integrations, self-checkout solutions, and embedded finance are all part of the same mission: helping operators understand what matters to their business so they can make informed decisions with confidence.”

Attendees visiting Booth #1929 will see Nayax’s platform in action across the full commerce journey: from payment acceptance and compliance management through loyalty, embedded finance, AI-powered operational insights, and consumer engagement.

Carly Furman will present on the NAMA mainstage in the session: “Payments & Security: Turning Complexity into Opportunity” – Thursday, April 23, 2026, 2:00 -2:30 PM, joined by co-presenters and Nayax partners Lance Whorton from Imperial and Jason Scherer from Pelican Group.

About Nayax

Nayax is a global commerce enablement, payments and loyalty platform designed to help merchants scale their business. Nayax offers a complete solution including localized cashless payment acceptance, management suite, and loyalty tools, enabling merchants to conduct commerce anywhere, at any time. With foundations and global leadership in serving unattended retail, Nayax has transformed into a comprehensive solution focused on our customers’ growth across multiple channels. As of December 31, 2025, Nayax has 13 global offices, approximately 1,200 employees, connections to more than 80 merchant acquirers and payment method integrations and is globally recognized as a payment facilitator. Nayax’s mission is to improve our customers’ revenue potential and operational efficiency – effectively and simply. For more information, please visit www.nayax.com.

Forward-Looking Statements

This press release contains statements that constitute forward-looking statements. Many of the forward-looking statements contained in this press release can be identified by the use of forward-looking words such as “anticipate,” “believe,” “could,” “expect,” “should,” “plan,” “intend,” “estimate” and “potential,” among others. Forward-looking statements include, but are not limited to, statements regarding our intent, belief or current expectations, such as statements in this press release regarding our financial outlook, future business prospects and the impact of recent acquisitions or partnerships published by the Company. Forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to: our expectations regarding general market conditions, including as a result of the COVID-19 pandemic and other global economic trends; changes in consumer tastes and preferences; fluctuations in inflation, interest rate and exchange rates in the global economic environment; the availability of qualified personnel and the ability to retain such personnel; changes in commodity costs, labor, distribution and other operating costs; our ability to implement our growth strategy; changes in government regulation and tax matters; other factors that may affect our financial condition, liquidity and results of operations; general economic, political, demographic and business conditions in Israel, including the war in Israel that began on October 7, 2023 and global perspectives regarding that conflict; the success of operating initiatives, including advertising and promotional efforts and new product and concept development by us and our competitors; and other risk factors discussed under “Risk Factors” in our annual report on Form 20-F filed with the SEC on March 9, 2026 (our “Annual Report”). The preceding list is not intended to be an exhaustive list of all of our forward-looking statements. The forward-looking statements are based on our beliefs, assumptions and expectations of future performance, taking into account the information currently available to us. These statements are only estimates based upon our current expectations and projections about future events. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements. In particular, you should consider the risks provided under “Risk Factors” in our Annual Report. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Each forward-looking statement speaks only as of the date of the particular statement. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, to conform these statements to actual results or to changes in our expectations.

Nayax Public Relations Contact:

Scott Gamm
Strategy Voice Associates
[email protected]

Nayax Investor Relations Contact:

Aaron Greenberg
Chief Strategy Officer
[email protected]

 



Posted on

Turbo Energy and Hithium Partner to Integrate AI-Driven Energy Optimization Software Into Battery Storage Systems Across Europe and Latin America

Partnership enables the integration of Turbo Energy’s AI-driven software into battery storage systems, supporting expansion of its high-margin international C&I pipeline

Hithium battery storage system powered by Turbo Energy’s AI-driven optimization platform

VALENCIA, Spain, April 20, 2026 (GLOBE NEWSWIRE) — Turbo Energy, S.A. (Nasdaq: TURB) (“Turbo Energy” or the “Company”), a global integrator of AI-driven solar energy storage solutions and intelligent energy management systems, today announced strategic partnership with Hithium, a tier 1 global battery storage provider, to integrate its AI-driven optimization platform into Hithium’s battery systems. The collaboration enables the deployment of intelligent, software-defined energy storage infrastructure across commercial and industrial (“C&I”) applications in Europe and Latin America.

Under the agreement, Turbo Energy will integrate its proprietary AI-driven software platform with Hithium’s battery storage systems, delivering fully optimized, end-to-end solar energy solutions tailored to complex C&I environments. Turbo Energy’s software transforms battery systems into adaptive, optimized energy assets capable of improving efficiency, reducing exposure to energy price volatility and enhancing operational resilience.

This strategic partnership builds on Turbo Energy’s growing portfolio of large-scale industrial deployments, a recently secured $53 million contract to deploy approximately 366 MWh of solar energy storage capacity across more than ten industrial facilities in Spain for a major industrial group, where Turbo Energy delivers turnkey integration of solar generation, battery storage and AI-driven energy management solutions.

The agreement is expected to support multi-market deployment across Europe and Latin America, leveraging Hithium’s global scale while accelerating Turbo Energy’s expansion in high-growth C&I segments. As a result, Turbo Energy anticipates continued expansion of its international project pipeline, with increasing contribution from higher-margin, software-driven and integrated energy management services.

“Energy storage is no longer defined by hardware alone — it is defined by how intelligently that infrastructure operates,” said Mariano Soria, Chief Executive Officer of Turbo Energy. “Our AI-driven platform enables battery systems to function as dynamic, optimized energy assets, and we are increasingly seeing global leaders integrate intelligence as a core layer of next-generation solar energy systems.”

“By combining Hithium’s global scale in battery storage with our optimization and integration capabilities, we are driving a new generation of software-defined energy infrastructure designed to deliver measurable economic value for industrial and commercial customers,” Soria added.

Partnering with Turbo Energy marks an important step in advancing the role of intelligent energy storage in global energy markets,” said Kelson Li, Vice President of Hithium Europe. “As a top two global provider of energy storage batteries and utility-scale battery shipments in 2025, Hithium is uniquely positioned to scale next-generation solutions. This collaboration enables us to combine our advanced battery technologies with AI-driven optimization to deliver high-impact, software-defined systems that unlock greater economic value for customers and accelerate the transition toward more flexible, decentralized energy infrastructure.

As energy systems continue to evolve toward greater complexity and decentralization, Turbo Energy remains focused on expanding its international footprint through strategic partnerships and scalable deployments. Turbo Energy is positioning its technology integration capabilities and proprietary software development to play a central role in the next phase of the energy transition, where performance, flexibility and economic optimization will define competitive advantage.

About Turbo Energy, S.A.

Founded in 2013, Turbo Energy, S.A. (Nasdaq: TURB) is a global integrator of AI-driven solar energy storage solutions and intelligent energy management systems. Turbo Energy’s technology platform enables residential, commercial and industrial customers to reduce energy costs, improve efficiency, enhance resilience and transform energy consumption into a controllable and optimized asset. As part of Umbrella Global Energy, Turbo Energy plays a central role as the Group’s technology platform, driving innovation in energy storage, electrification and intelligent energy management across international markets in Europe, North America and Latin America. For more information, please visit www.turbo-e.com.

About Hithium

Founded in 2019, HiTHIUM is a leading global company in renewable energy technology, committed to delivering energy storage solutions centered on advanced energy storage battery and system technologies. With robust research, production, sales, and service capabilities worldwide, HiTHIUM is the only energy storage-focused company to achieve GWh-scale global shipments of lithium-ion ESS batteries, reaching a milestone of over 100 GWh in cumulative shipments in 2025. Capping off a remarkable year, HiTHIUM secured the Top 2 position globally for both total energy storage battery shipments and utility-scale battery shipments in 2025, according to authoritative institutions including InfoLink, SMM, and ICC. Through HiTHIUM Europe, the company now delivers to over 18 European countries, including the world’s first 1175Ah project. Its customer-centric approach drives cutting-edge products and solutions for customers all over the world.

Forward-Looking Statements


Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on current beliefs, expectations and assumptions regarding the future of the business of the Company, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control, including the risks described in the Company’s registration statements and annual report under the heading “Risk Factors” as filed with the Securities and Exchange Commission. Actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Any forward-looking statements contained in this press release speak only as of the date hereof, and Turbo Energy, S.A. specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

For more information, please contact:                    

Dodi Handy, Director of Communications                    
Phone: 407-960-4636                                                
Email: [email protected]

Attachment



Posted on

Letter to Surf Air Mobility Inc. Shareholders from Chairman of the Board, CEO, and Co-Founder

Letter to Surf Air Mobility Inc. Shareholders from Chairman of the Board, CEO, and Co-Founder

LOS ANGELES–(BUSINESS WIRE)–
Surf Air Mobility Inc. (NYSE: SRFM):

Fellow Shareholders,

As we execute the 2026 plan, we are taking this moment to update you on what is working, what is not, and what we are doing about both.

Convergence of AI-enabled software and electric aircraft will reshape the future of aviation. We are building the platform at the center of this transformation.

SurfOS, the AI-enabled operating system we are building with Palantir, is the digital infrastructure of our platform. Two airlines, a growing charter business, and our electrification partnership with BETA Technologies are the proof points, and 2026 is the year our use of the platform starts showing up in the numbers.

Improving 2026 Adjusted EBITDA Loss Guidance by Approximately 40%

We have revised our 2026 guidance for Adjusted EBITDA loss to $30 to $25 million, an approximate 40% improvement from the prior Adjusted EBITDA loss of $50 to $40 million. Revenue guidance is unchanged at $128-$138 million, a 20-30% growth over 2025.

Our improved Adjusted EBITDA is a result of four key drivers:

  • SurfOS digitalizing core airline and charter workflows, reducing costs by 6% and 15%, respectively

  • Corporate automation and procurement discipline, 32% reduction in staffing need, 17% in professional services

  • Increased profitable charter revenue through the capital-efficient Powered by Surf On Demand program

  • Reduced SurfOS development costs and accelerating deployment via AI and Palantir’s platform

$30 Million in New Capital Structured to Minimize Dilution and Execute Our 2026 Plan

Today, we announced two transactions resulting in $30 million of new capital: $15 million of non-dilutive, aircraft-backed credit, and $15 million of common equity led by our Co-Founders, with officers, directors, and existing institutional partners participating alongside. We are obtaining liquidity in the least dilutive manner and chose this path because we believe in the plan and are investing our own money behind it.

SurfOS is Now Driving Measurable Results

We spent 2025 capturing data within our operations and building SurfOS, the AI-enabled operating system at the core of the platform, powered by Palantir’s AIP and Foundry. SurfOS optimizes scheduling, fuel, maintenance, crew, and revenue across our operations.

SurfOS is having a tremendous impact on our business, and as we continue to digitize our operations we will deploy software at a faster pace. Below are some highlights:

Airline Operations, Southern Airways and Mokulele Airlines:

  • Controllable completion rate hit 98% in Q4 2025

  • On-time departures up 10+ percentage points year-over-year

  • $1.3 million of incremental EBITDA expected from airline optimization this year, driven by SurfOS-enabled improvements across crew, fleet, fuel utilization, spare parts discipline, and load factor optimization

Surf On Demand Private Charter, our fastest-growing business:

  • Q4 2025 charter revenue +36% year-over-year using BrokerOS

  • Powered by Surf On Demand program empowering independent brokers: six independent brokers live, 23 in the pipeline, and 100 by year-end

  • 32% more bookings for top brokers, 57% faster quote-to-close, 40% more payments processed on platform Q1 2026 vs. Q1 2025

The more data that flows through SurfOS, the smarter and more predictive it gets. That compounding advantage cannot be copied overnight and it is our moat.

Commercializing SurfOS

  • BrokerOS (commercially launched in December 2025):Independent brokers join Powered by Surf On Demand to sell under our brand using our software. We take a share of per-flight profit. We have 29 brokers enrolled, and hundreds of applicants in the queue.
  • OperatorOS (launching 2H 2026):Small and mid-sized operators will integrate into the platform with tools to optimize their operations. Our target is 10 LOIs signed and five operators onboarded by year-end. OperatorOS is designed to maximize real-time pricing and availability of aircraft to best enable our brokers.
  • SurfOS for Enterprise (active pipeline):Custom solutions for large operators, brokerages, and aircraft OEMs. Multi-year, multi-million-dollar contracts targeted this year. Through our exclusive teaming agreement with Palantir, their forward-deployed team is in every enterprise conversation with us.

We will consistently communicate key milestones as we commercialize SurfOS with Palantir, so you can track our progress against these targets.

Hawaii is Our Launchpad for Electric Aviation

Electrification is another core element of our platform thesis. Our Mokulele Airlines operates Hawaii’s largest airline network by departures and airports served. Short inter-island routes, entrenched route authority, and deep community ties make it the right testbed for electric aviation. In 2026, BETA’s electric aircraft will be operated on Mokulele Airlines cargo demonstration routes in Hawaii, laying the operational foundation for passenger service.

Our strategic partnership with BETA Technologies allows us to capture the benefits of electrification at a fraction of the cost and at a faster pace. We have eliminated up to $100 million in planned Cessna Caravan electrification spend, significantly limiting potential dilution. We still see a strong use case for an electric Caravan in markets like Hawaii and are exploring partner paths to advance that program.

What to watch in 2026

This plan is built on milestones. Here are the ones worth watching:

  • Digitalization and optimization of our airline operations

  • Surf On Demand private charter revenue and margin expansion

  • 100 brokers onboarded to Powered by Surf On Demand

  • 10 OperatorOS LOIs signed, 5 operators live

  • First SurfOS Enterprise contracts signed

  • BETA electric cargo demonstration flights in Hawaii

A final word

To our shareholders who have invested with us throughout our transformation, our platform is seeing momentum. The software is live. The partners are committed. Our own capital is in this round. And the operating numbers are moving in the right direction.

Thank you for owning SRFM and being part of the future of aviation.

Carl Albert

Chairman of the Board

Deanna White

Chief Executive Officer

Sudhin Shahani

Co-Founder

About Surf Air Mobility

Surf Air Mobility is a Los Angeles-based air mobility platform. With its AI-enabled SurfOS software and electrification programs, Surf Air Mobility provides technology designed to support the modernization of air operations and the adoption of next-generation aircraft. The Company currently operates one of the largest commuter airlines in the United States by scheduled departures, which provides operational scale and real-world operating data to validate and deploy its software. Together, these capabilities position Surf Air Mobility as a leader shaping a more efficient, connected, and accessible future for aviation.

Forward-Looking Statements

This Press Release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, including statements regarding Surf Air Mobility’s implementation of its transformation strategy; developments on key strategic initiatives; Surf Air Mobility’s profitability and future financial results; and Surf Air Mobility’s balance sheet and liquidity. Readers of this release should be aware of the speculative nature of forward-looking statements. These statements are based on the beliefs of Surf Air Mobility’s management as well as assumptions made by and information currently available to Surf Air Mobility and reflect Surf Air Mobility’s current views concerning future events. As such, they are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, among many others: Surf Air Mobility’s future ability to pay contractual obligations and liquidity will depend on operating performance, cash flow and ability to secure adequate financing; Surf Air Mobility’s limited operating history and that Surf Air Mobility has not yet commercialized software platforms for third-party sales or manufactured any hybrid-electric or fully-electric aircraft; Surf Air Mobility’s failure to realize the expected return on its significant investment in SurfOS due to development delays, technical challenges, or lack of market acceptance; any accidents or incidents involving hybrid-electric or fully-electric aircraft; the dependence on third-party partners and suppliers for the components and collaboration in Surf Air Mobility’s development of hybrid-electric and fully-electric powertrains and its advanced air mobility software platform, and any interruptions, disagreements or delays with those partners and suppliers; the inability to execute business objectives and growth strategies successfully or sustain Surf Air Mobility’s growth; the inability of Surf Air Mobility’s customers to pay for Surf Air Mobility’s services; the inability of Surf Air Mobility to obtain additional financing or access the capital markets to fund its ongoing operations on acceptable terms and conditions; the outcome of any legal proceedings that might be instituted against Surf Air, Southern or Surf Air Mobility, the risks associated with Surf Air Mobility’s obligations to comply with applicable laws, government regulations and rules and standards of the New York Stock Exchange; and general economic conditions. These and other risks are discussed in detail in the periodic reports that Surf Air Mobility files with the SEC, and investors are urged to review those periodic reports and Surf Air Mobility’s other filings with the SEC, which are accessible on the SEC’s website at www.sec.gov, before making an investment decision. Surf Air Mobility assumes no obligation to update its forward-looking statements except as required by law.

Surf Air Mobility Media Contacts

Press: [email protected]

Investors: [email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Air Technology Aerospace Transport Manufacturing Software Artificial Intelligence

MEDIA:

Logo
Logo
Posted on

Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions

NEW YORK and TORONTO, April 20, 2026 (GLOBE NEWSWIRE) — Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP), a clinical stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), today welcomed the White House Executive Order aimed at accelerating research, regulatory pathways, and patient access to psychedelic treatments.

“The Executive Order reflects growing recognition of the urgent need for new treatment options in serious mental health conditions and the importance of advancing innovative therapies through rigorous, research-based development,” said Eric So, Interim Chief Executive Officer of Helus Pharma. “Policy momentum is meaningful, but the future of this field will ultimately be determined by the strength of the clinical evidence and the ability to deliver safe, reliable treatments at scale.”

The Executive Order introduces several key initiatives, including the potential prioritization of U.S. Food and Drug Administration (“FDA”) review for psychedelic therapies with Breakthrough Therapy designation, expanded access for eligible patients, increased federal funding to support state-level programs, and strengthened coordination between the Department of Health and Human Services, the FDA, and the Department of Veterans Affairs. It also calls for timely rescheduling of therapies that successfully complete late-stage clinical development and receive regulatory approval, reinforcing a policy framework that supports continued innovation across the psychedelic treatment landscape.

“At Helus Pharma, we are contributing to that progress through disciplined research and late-stage clinical development,” Mr. So added. “Our lead program, HLP003, currently in Phase 3 development, has received FDA Breakthrough Therapy designation for the adjunctive treatment of major depressive disorder, reflecting the urgent need for improved treatments for depression, including the ongoing epidemic of suicide in the United States.”

Helus Pharma believes these actions will help advance the development of novel treatment options for patients living with mental health conditions including major depressive disorder and generalized anxiety disorder, where existing therapies are often insufficient. Millions of patients living with serious mental health conditions continue to experience inadequate response to existing therapies, underscoring the importance of responsible innovation in this area.

Helus Pharma continues to advance its pipeline of investigational therapies and to engage with regulators, clinicians, and research partners to advance its innovative treatments.

About Helus Pharma

Helus Pharma™, the commercial operating name of Cybin Inc. (the “Company” or “Helus Pharma”) is a clinical stage pharmaceutical company committed to helping minds heal by developing proprietary NSAs – novel serotonergic agonists: synthetic molecules designed to activate serotonin pathways that are believed to promote neuroplasticity. The Company’s proprietary NSAs are intended to address the large unmet need for people who suffer from depression, anxiety, and other mental health conditions.

With class leading data, Helus Pharma aims to improve the treatment landscape through the introduction of NSAs that aim to provide durable improvements in mental health. Helus Pharma is currently developing HLP003, a proprietary NSA, in Phase 3 clinical development for the adjunctive treatment of major depressive disorder that has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration and HLP004, also a proprietary NSA in Phase 2 for generalized anxiety disorder. Additionally, Helus Pharma has an extensive research portfolio of investigational NSAs.

The Company operates in Canada, the United States, the United Kingdom, and Ireland. For Company updates and to learn more about Helus Pharma, visit www.helus.com or follow the team on X, LinkedIn, YouTube and Instagram. Helus Pharma™ is a trademark of Cybin Corp.

Cautionary Notes and Forward-Looking Statements

Certain statements in this news release relating to the Company are forward-looking statements or forward-looking information within the meaning of applicable securities laws (collectively, “forward-looking statements”) and are prospective in nature. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. These statements generally can be identified by the use of forward-looking words such as “may”, “should”, “could”, “potential”, “possible”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe” or “continue”, or the negative thereof or similar variations. Forward-looking statements in this news release include statements regarding the Company’s belief that the Executive Order will help advance the development of novel treatment options for mental health conditions including major depressive disorder; expectation that the Executive Order may accelerate research, regulatory pathways, and patient access to psychedelic treatments; and plans to engineer proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health conditions.

These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the NSA market; the ability of the Company to successfully achieve its business objectives; plans for growth; political, social and environmental uncertainties; employee relations; the presence of laws and regulations that may impose restrictions in the markets where the Company operates; implications of disease outbreaks on the Company’s operations; and the risk factors set out in each of the Company’s management’s discussion and analysis for the three and nine month periods ended December 31, 2025, and the Company’s annual information form for the year ended March 31, 2025, which are available under the Company’s profile on SEDAR+ at www.sedarplus.ca and with the U.S. Securities and Exchange Commission on EDGAR at www.sec.gov/edgar. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

The Company makes no medical, treatment or health benefit claims about the Company’s proposed products. The U.S. Food and Drug Administration, Health Canada or other similar regulatory authorities have not evaluated claims regarding NSAs or HLP003, HLP004 and other programs of the Company. The efficacy of such products has not been confirmed by approved research. There is no assurance that the use of NSAs, HLP003, HLP004 or other programs of the Company can diagnose, treat, cure or prevent any disease or condition. Rigorous scientific research and clinical trials are needed. If Helus Pharma cannot obtain the approvals or research necessary to commercialize its business, it may have a material adverse effect on the Company’s performance and operations.

Neither Cboe Canada, nor the Nasdaq Global Market stock exchange, have approved or disapproved the contents of this news release and are not responsible for the adequacy and accuracy of the contents herein.

Investor Contact:

Matthew Beck
astr partners
Managing Partner
(917) 415-1750
[email protected]

George Tziras
Chief Business Officer
Helus Pharma
1-866-292-4601
[email protected] – or – [email protected]

Media Contact:

Johnny Tokarczyk
RXMD
Public Relations Director
[email protected]
(914) 772-7562



Posted on

Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics’ RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients

Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics’ RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients

Peer-reviewed study finds standard HER2 IHC testing shows limited predictive value for T-DXd while Ignite’s platform — the only commercially available multiplex assay in the study—demonstrates predictive value for patient outcomes

MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–
Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, today announced that its precision oncology subsidiary, Ignite Proteomics, LLC (“Ignite” or “Ignite Proteomics”), has been featured in a peer-reviewed study published online ahead of print in npj Precision Oncology, a Nature journal. The study, led by investigators at Dana-Farber Cancer Institute, evaluated outcomes among patients with metastatic breast cancer treated with trastuzumab deruxtecan (T-DXd, marketed as Enhertu® by AstraZeneca and Daiichi Sankyo) and assessed multiple quantitative HER2-related assays for their association with treatment outcomes.

While conventional HER2 immunohistochemistry (IHC) showed some association with outcomes in the broader patient population, the study found that quantitative HER2-related assays provided more granular predictive information in several matched biomarker sub-cohorts. In those sub-cohorts, traditional IHC classification often showed limited predictive value compared with quantitative approaches. Ignite’s Reverse Phase Protein Array (RPPA) platform, the only commercially available multiplex assay in the study, was one of the quantitative methods that demonstrated meaningful predictive value for patient outcomes.

T-DXd is an approved treatment option for a broad population of patients with metastatic breast cancer, yet there is currently no reliable way to predict which patients will respond.

“According to several studies, approximately 40% of cancers do not respond to the FDA approved therapy at front line in a metastatic setting,” said Jeff Busch, Chief Executive Officer of Ignite Proteomics. In oncology, published research and institutional analyses have shown that approved therapies often fail to benefit a substantial portion of the patients who receive them. A 2017 study published in the BMJ reported that 57% of cancer drug indications approved by the European Medicines Agency entered the market without evidence of improved survival or quality-of-life benefit. MIT researchers have noted that targeted tyrosine kinase inhibitors typically work for only 40% to 80% of patients expected to respond. Johns Hopkins has reported that only 15% to 20% of patients achieve durable results with immunotherapy.

Ignite’s RPPA platform measures multiple protein biomarkers, including pathway activation and payload-relevant markers, from a single tumor sample. In the Dana-Farber study, Ignite’s platform was the only commercially available multiplex assay evaluated and demonstrated predictive value in matched biomarker cohorts where conventional HER2 IHC showed limitations. Notably, the study found that TOPO1 expression, the target of T-DXd’s cytotoxic payload, was detectable by Ignite’s platform in certain HER2-negative patients, highlighting the potential value of measuring tumor biology beyond HER2 expression alone. Ignite’s assay is CLIA-certified, CAP-accredited, listed on the Medicare Clinical Laboratory Fee Schedule under AMA CPT code PLA 0249U, and orderable today on standard biopsy tissue.

“Cancer therapy has made extraordinary progress, but oncology still has a treatment-selection problem,” added Busch. “Too many patients receive therapies without enough information about whether those therapies are likely to work for their tumor biology. That is not an indictment of the drugs. These are powerful therapies. The issue is that cancer is complex, and single-marker testing often does not capture the functional biology that drives response or resistance. Ignite’s RPPA platform was built to address that gap by measuring multiple proteins, pathway activation, and payload-relevant biology from the same tumor sample. In this study, one of the world’s leading breast cancer research teams evaluated our platform alongside standard testing, and our platform demonstrated predictive value where conventional testing had limitations. That is the opportunity: better data, better treatment selection, and fewer patients receiving therapies that were never likely to help them.”

“This publication represents an important milestone for our subsidiary Ignite and reflects the strength of Aditxt’s model of advancing and scaling impactful health innovations,” said Amro Albanna, Co-Founder and Chief Executive Officer of Aditxt. “Peer-reviewed clinical evidence from one of the world’s leading cancer research institutions is key to accelerating the commercialization of this platform and expanding access to it for millions of patients making treatment decisions without clear guidance on what will work. Our goal is to help ensure that more patients receive the right therapy at the right time, with the potential to improve outcomes and make a meaningful difference in people’s lives.”

The full study is available open access at: https://doi.org/10.1038/s41698-026-01365-6

About Ignite Proteomics, LLC

Ignite Proteomics delivers pathway‑level protein analytics to guide precision oncology. Operating a CLIA‑certified, CAP‑accredited laboratory, Ignite’s clinical RPPA assay quantifies 32 phospho- and total-protein biomarkers from limited biopsy material to support oncology research and clinical decision making.

About Aditxt, Inc.

Aditxt, Inc. is a social innovation platform accelerating promising health innovations. Aditxt’s ecosystem of research institutions, industry partners, and shareholders collaboratively drives its mission to “Make Promising Innovations Possible Together.” The innovation platform is the cornerstone of Aditxt’s strategy, where multiple disciplines drive disruptive growth and address significant societal challenges. Aditxt operates a unique model that democratizes innovation, ensures every stakeholder’s voice is heard and valued, and empowers collective progress. The Company currently operates four programs focused on autoimmunity, cancer and early disease detection, infectious diseases and women’s health.

Forward-Looking Statements

This press release includes “forward-looking statements,” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as “aim,” “believe,” “could,” “expect,” “intend,” “may,” “plan,” “potential,” “seek,” “will,” and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to, statements regarding the significance of the published study, Ignite’s commercialization plans, the potential clinical utility of its platform, expected collaborations, publications, reimbursement, adoption, and international expansion. You are cautioned not to place undue reliance on these forward-looking statements, which are current only as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Important factors that could cause actual results to differ materially from those discussed or implied in the forward-looking statements are disclosed in each company’s SEC filings, including Aditxt’s Annual Report on Form 10-K and any subsequent Form 10-Q filings, including the most recent filed on November 18, 2025. All forward-looking statements are expressly qualified in their entirety by such factors. Aditxt undertakes no duty to update any forward-looking statement except as required by law.

Aditxt, Inc.

Investor Relations

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Oncology Health Clinical Trials Research Science Pharmaceutical Biotechnology

MEDIA:

Posted on

VENU’s Terri Liebler, President of Growth and Strategy, and Joanna Brown, Vice President and Executive Creative Director, Named Executive Honorees on Billboard’s 2026 Women in Music List

VENU’s Terri Liebler, President of Growth and Strategy, and Joanna Brown, Vice President and Executive Creative Director, Named Executive Honorees on Billboard’s 2026 Women in Music List

VENU’s brand architects earn their place among the music industry’s most influential women.

COLORADO SPRINGS, Colo.–(BUSINESS WIRE)–Venu Holding Corporation (“VENU” or the “Company”) (NYSE American: VENU), owner, operator, and developer of premium live entertainment destinations, today announced that VENU™ executives Terri Liebler, President of Growth and Strategy, and Joanna Brown, Vice President and Executive Creative Director, have been named Executive Honorees on Billboard’s 2026 Women in Music list. The ceremony recognizing the honorees will be held on Wednesday, April 29, 2026, at the Hollywood Palladium in Los Angeles, hosted by Keke Palmer.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260420452275/en/

VENU's Terri Liebler, President of Growth and Strategy, and Joanna Brown, Vice President and Executive Creative Director, Named Executive Honorees on Billboard's 2026 Women in Music List

VENU’s Terri Liebler, President of Growth and Strategy, and Joanna Brown, Vice President and Executive Creative Director, Named Executive Honorees on Billboard’s 2026 Women in Music List

Billboard’s Women in Music is one of the most prestigious recognitions in the music industry, celebrating the executives and artists who are driving the roaring music business forward. Being named an Executive Honoree places Liebler and Brown among an elite group of women who are not only shaping their companies but defining the direction of the industry itself.

Over the past year, Terri Liebler has transformed the VENU brand into a leading platform, positioning the company to attract top partners, artists, and market opportunities. She has generated nearly $30 million in investments and sponsorship revenue to date and leads a team focused on strategic partnerships and innovative revenue streams. Liebler has secured partnerships with Aramark Sports + Entertainment, PepsiCo, Tixr, and Boston Common Golf, a TGL team led by Rory McIlroy. She also played a key role in bringing Dierks Bentley and Niall Horan on as VENU shareholders. Her contributions have been transformational.

Joanna Brown has shaped VENU’s brand identity during a pivotal period, guiding the company from pre-IPO through its NYSE American debut and beyond. As Vice President and Executive Creative Director, she established VENU’s fan-founded, fan-owned, and artist-inspired brand and oversees creative strategy across VENU’s portfolio. Brown leads integrated marketing campaigns and directs a multidisciplinary creative team in design, development, animation, video, and advanced AI initiatives. Her work defines the premium live experience at the intersection of entertainment, hospitality, and fandom.

“I have spent a long time in this industry, and this is one of those acknowledgements and moments that make it all worthwhile,” said Terri Liebler, President of Growth and Strategy, VENU. “To stand alongside the trailblazers who made space for the rest of us is something I will always be grateful for. Thank you to Billboard and to the entire VENU team.”

“Building this brand alongside such a talented team has been one of the greatest achievements of my career,” said Joanna Brown, Vice President and Executive Creative Director, VENU. “To have that work recognized by Billboard is something I will never forget. Congratulations to all the honorees.”

“Terri and Joanna have been instrumental in building what VENU is today,” said J.W. Roth, Founder, Chairman, and CEO of VENU. “To see them recognized by Billboard alongside the most influential women in the music industry is a proud moment for our entire company. Congratulations!”

Billboard’s Women in Music 2026 will be held at the Hollywood Palladium in Los Angeles on Wednesday, April 29, 2026, hosted by Emmy-winning entertainer Keke Palmer. The event recognizes artists and executives whose contributions are transforming the music industry.

About Venu Holding Corporation

Venu Holding Corporation (“VENU”) (NYSE American: VENU) is a premier owner, developer, and operator of luxury, experience-driven entertainment destinations. Founded by Colorado Springs entrepreneur J.W. Roth, VENU™ has a portfolio of premium brands that includes Ford Amphitheater, Sunset Amphitheaters, Phil Long Music Hall, The Hall at Bourbon Brothers, Bourbon Brothers Smokehouse and Tavern, Aikman Owners Clubs, and Roth’s Sea & Steak. With venues operating and in development across Colorado, Georgia, Oklahoma, and Texas and a nationwide expansion underway, VENU™ is setting a new standard for live entertainment.

VENU has been recognized nationally by The Wall Street Journal, The New York Times, Billboard, VenuesNow, and Variety for its innovative and disruptive approach to live entertainment. Through strategic partnerships with industry leaders such as AEG Presents, NFL Hall of Famer and Founder of EIGHT Elite Light Beer, Troy Aikman, Aramark Sports + Entertainment, Tixr, Niall Horan, and Dierks Bentley. VENU continues to shape the future of the entertainment landscape. For more information, visit VENU’s website, Instagram, LinkedIn, or X.

Forward Looking Statements

Certain statements in this press release constitute “forward-looking statements” within the meaning of the federal securities laws. Words such as “may,” “might,” “will,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,” “plan,” “intend” or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While Venu believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the company’s filings with the SEC, not limited to Risk Factors relating to its business contained therein. Thus, actual results could be materially different. Venu expressly disclaims any obligation to update or alter statements whether because of new information, future events or otherwise, except as required by law.

VENU Media Relations

Chloe Polhamus, [email protected]

VENU Investor Relations

Sarah Rothschild, [email protected]

KEYWORDS: California Colorado United States North America

INDUSTRY KEYWORDS: Sports General Sports Commercial Building & Real Estate Music Construction & Property Women Marketing Events/Concerts Entertainment Communications Consumer

MEDIA:

Photo
Photo
VENU’s Terri Liebler, President of Growth and Strategy, and Joanna Brown, Vice President and Executive Creative Director, Named Executive Honorees on Billboard’s 2026 Women in Music List
Logo
Logo
Posted on

Nanox Signs Commercial Agreement with Howard Technology Solutions to Deploy 300 Nanox.ARC Systems Across U.S. Over Three Years

Howard’s nationwide reach across healthcare and public sector markets expands Nanox’s U.S. channel partner network to additional customer segments

PETAH TIKVA, Israel, April 20, 2026 — Nano-X Imaging Ltd. (“Nanox”, or the “Company”, Nasdaq: NNOX), a leader in innovative medical imaging technology, today announced a strategic commercial agreement with Howard Technology Solutions, a leading U.S.-based technology solutions provider with deep expertise in healthcare and a broad national footprint.

The agreement will support the commercial rollout of the Nanox.ARC, an FDA-cleared, multisource digital tomosynthesis system that makes 3D imaging possible in more clinical settings, at a lower cost and reduced radiation dose compared to traditional CT.

Under the terms of the agreement, Howard Technology Solutions will market and deploy 300 Nanox.ARC systems over a three-year period, 60 for the first year, and introduce the system to healthcare facilities and public sector customers across its national network.

“We are pleased to welcome Howard Technology Solutions as our newest U.S. distribution partner,” commented Erez Meltzer, CEO and Acting Chairman of Nanox. “Howard’s national reach and established presence in healthcare and public sector markets give us a scalable framework for expanding Nanox.ARC deployments. This agreement reflects our confidence in the commercial demand for the Nanox.ARC and our ability to engage partners that can support sustained growth in system placements across the U.S.”

“The Nanox.ARC is unlike anything currently in our portfolio, bringing advanced 3D imaging to facilities that haven’t previously had access to this kind of diagnostic capability,” said Frank Blanco, Vice President of Purchasing, of Howard Technology Solutions. “We see strong potential across our healthcare and public sector customer base, and our nationwide deployment infrastructure is well-suited to support Nanox’s commercial rollout at scale.”

Howard Technology Solutions, a division of Howard Industries, provides technology procurement, deployment, and support services to healthcare facilities, government agencies, and public sector organizations across the U.S. It enables the deployment and support of clinical technologies for its complementary line of healthcare technology products, including point-of-care, medication carts, workstation-on-wheels, telehealth solutions, and computer hardware.

The company’s national sales and service infrastructure, combined with its established relationships in markets that have traditionally been underserved by medical imaging distributors, positions it well to introduce the Nanox.ARC to new customer segments.

About Nanox

Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform.

Nanox combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care.

Nanox’s vision is to expand the reach of medical imaging both within and beyond traditional hospital settings by providing a seamless solution from scan to interpretation and beyond. By leveraging proprietary digital X-ray technology, AI-driven analytics, and a clinically driven approach, Nanox aims to enhance the efficiency of routine imaging workflows, support early detection of disease, and improve patient outcomes.

The Nanox ecosystem includes Nanox.ARC, a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.

By integrating imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology, Nanox seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide. For more information, please visit www.nanox.vision

About Howard Technology Solutions

Howard Technology Solutions’ Medical Division is a premier manufacturer and provider of healthcare technology, specializing in point-of-care (POC) medication carts, workstation-on-wheels, telehealth solutions, and computer hardware serving hospitals and clinics throughout the U.S. 

Founded in 2003, they serve hospitals and clinics by producing durable, U.S.-assembled equipment designed to improve patient care and clinician efficiency.

In addition to these products, Howard provides specialized services including on-site setup, installation, and, in some cases, tailored technology training.

From our own Howard manufactured products, such as desktops, notebooks, servers, kiosks, and medical carts to partner products from other leading technology innovators, such as Lenovo, HP, and Microsoft, you can be sure when you buy from Howard that you are getting the most for your technology dollars. For more information, please visit https://howard.com/index.cfm

Forward-Looking Statements

This press release may contain forward-looking statements that are subject to risks and uncertainties. All statements that are not historical facts contained in this press release are forward-looking statements. Such statements include, but are not limited to, any statements relating to the initiation, timing, progress and results of the Company’s research and development, manufacturing, and commercialization activities with respect to its X-ray source technology and the Nanox.ARC, the ability to realize the expected benefits of its recent acquisitions and the projected business prospects of the Company and the acquired companies. In some cases, you can identify forward-looking statements by terminology such as “can,” “might,” “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “should,” “could,” “expect,” “predict,” “potential,” or the negative of these terms or other similar expressions. Forward-looking statements are based on information the Company has when those statements are made or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Factors that could cause actual results to differ materially from those currently anticipated include: risks related to (i) Nanox’s ability to complete development of the Nanox System; (ii) Nanox’s ability to successfully demonstrate the feasibility of its technology for commercial applications; (iii) Nanox’s expectations regarding the necessity of, timing of filing for, and receipt and maintenance of, regulatory clearances or approvals regarding its technology, the Nanox.ARC and Nanox.CLOUD from regulatory agencies worldwide and its ongoing compliance with applicable quality standards and regulatory requirements; (iv) Nanox’s ability to realize the anticipated benefits of the acquisitions, which may be affected by, among other things, competition, brand recognition, the ability of the acquired companies to grow and manage growth profitably and retain their key employees; (v) Nanox’s ability to enter into and maintain commercially reasonable arrangements with third-party manufacturers and suppliers to manufacture the Nanox.ARC; (vi) the market acceptance of the Nanox System and the proposed pay-per-scan business model; (vii) Nanox’s expectations regarding collaborations with third-parties and their potential benefits; (viii) Nanox’s ability to conduct business globally; (ix) changes in global, political, economic, business, competitive, market and regulatory forces; (x) risks related to the current war between Israel and Hamas and any worsening of the situation in Israel; (xi) risks related to business interruptions resulting from the COVID-19 pandemic or similar public health crises, among other things; and (xii) potential litigation associated with our transactions.

For a discussion of other risks and uncertainties, and other important factors, any of which could cause Nanox’s actual results to differ from those contained in the Forward-Looking Statements, see the section titled “Risk Factors” in Nanox’s Annual Report on Form 20-F for the year ended December 31, 2024, and subsequent filings with the U.S. Securities and Exchange Commission. The reader should not place undue reliance on any forward-looking statements included in this press release. Except as required by law, Nanox undertakes no obligation to update publicly any forward-looking statements after the date of this press release to conform these statements to actual results or to changes in the Company’s expectations.

Contacts

Media Contact:

Ben Shannon
ICR Healthcare
[email protected]

Investor Contact:
Mike Cavanaugh
ICR Healthcare
[email protected]



Posted on

Coursera to Announce First Quarter 2026 Financial Results

Coursera to Announce First Quarter 2026 Financial Results

MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–
Coursera, Inc. (NYSE: COUR), a leading global online learning platform, today announced it will release its financial results for the first quarter ended March 31, 2026 after the U.S. stock market closes on Thursday, April 23, 2026. The company will issue the results via a press release with accompanying consolidated financial information before holding a conference call broadcast at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).

Conference Call Details

A live, audio-only webcast of the conference call and earnings release materials will be available to the public on the company’s investor relations website at investor.coursera.com. An archived replay will be accessible in the same location for one year.

Disclosure Information

In compliance with disclosure obligations under Regulation FD, Coursera announces material information to the public through a variety of means, including filings with the Securities and Exchange Commission (“SEC”), press releases, company blog posts, public conference calls, and webcasts, as well as via Coursera’s investor relations website.

About Coursera

Coursera was launched in 2012 by Andrew Ng and Daphne Koller with a mission to provide universal access to world-class learning. Today, it is one of the largest online learning platforms in the world, with 197 million registered learners as of December 31, 2025. Coursera partners with over 375 leading university and industry partners to offer a broad catalog of content and credentials, including courses, Specializations, Professional Certificates, and degrees. Coursera’s platform innovations — including generative AI-powered features like Coach, Role Play, and Course Builder, and role-based solutions like Skills Tracks — enable instructors, partners, and companies to deliver scalable, personalized, and verified learning. Institutions worldwide rely on Coursera to upskill and reskill their employees, students, and citizens in high-demand fields such as GenAI, data science, technology, and business, while learners globally turn to Coursera to master the skills they need to advance their careers. Coursera is a Delaware public benefit corporation and a B Corp.

Source Code: COUR-IR

For investors: Cam Carey,[email protected]

For media: Arunav Sinha, [email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Education Technology Software Other Education Continuing Internet Training

MEDIA:

Logo
Logo
Posted on

Foresight Enters Non-Binding Term Sheet for $17.5 Million Strategic Investment at Significant Premium to Current Market Price and Focus on Defense Collaboration

The strategic equity investment reflects a multiple of three times of Foresight’s current market value to reach a post investment valuation of approximately $35 million

NESS ZIONA, Israel, April 20, 2026 (GLOBE NEWSWIRE) — Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in 3D perception systems, today announced that it has entered into a non-binding term sheet with VisionWave Holdings, Inc. (Nasdaq: VWAV) (“VisionWave”), a defense and advanced sensing technology company.

Pursuant to the term sheet, at closing, VisionWave will make a strategic equity investment of up to $17.5 million (but not less than $15.45 million) through the issuance of VisionWave common stock based on the five-day average closing price of VisionWave’s common stock prior to closing. In exchange, VisionWave will receive Foresight’s ordinary shares representing up to 51% (but not less than 45%) of the Company’s issued and outstanding share capital. The transaction values Foresight at a significant premium with a multiple of approximately three times its current market value.

The Company believes that the $17.5 million investment will provide it with substantial financial strength to support ongoing operations, technology development, and commercialization of next-generation perception solutions.

As agreed in the term sheet, Foresight will place greater focus on the defense, military, and homeland security markets, areas in which it is already active. These fields benefit from strong synergy between Foresight’s advanced camera-based perception systems and VisionWave’s radio frequency (RF) and defense-focused technologies, along with VisionWave’s global business development capabilities and ongoing projects. This strategic collaboration is driven by Foresight’s business strategy to lead 3D perception applications, in challenging and extreme off-road and aerial environments, leveraging its technology advantages in these growing markets.

“We believe that Foresight’s unique stereo vision solutions, and especially its proprietary thermal camera expertise, which is complementary to VisionWave’s existing sensing technologies, is expected to have significant impact on VisionWave ability to deliver large scale military and defense projects to our customers, focusing on robotics, drones and unmanned aerial vehicles” said Douglas Davis, VisionWave’s executive chairman of the board and chief executive officer. “Thermal vision sensing is key to military, defense and homeland security markets, and VisionWave’s global presence is well positioned to promote Foresight’s strong technological capabilities to short term commercialization success.”

The transaction remains subject to completion of due diligence, negotiation and execution of definitive agreements, receipt of all required regulatory, stock-exchange and shareholder approvals, and other customary closing conditions.

About VisionWave Holdings Inc.

VisionWave Holdings, Inc. (Nasdaq: VWAV) is a defense and advanced sensing technology company developing AI-driven, RF-based sensing, autonomy, and computational acceleration technologies for defense, homeland security, and commercial infrastructure applications. VisionWave’s mission is to connect defense innovation with civilian progress through shared core technologies deployed across air, land, and sea.

About Foresight

Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) is a technology company developing advanced three-dimensional (3D) perception systems and cellular-based applications. Through its wholly owned subsidiaries, Foresight Automotive Ltd., Foresight Changzhou Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both “in-line-of-sight” vision systems and “beyond-line-of-sight” accident-prevention solutions.

Foresight’s 3D perception systems include modules of automatic calibration and dense 3D point cloud that can be applied to different markets such as automotive, defense, autonomous driving, agriculture, heavy industrial equipment and unmanned aerial vehicles (UAVs).

Eye-Net Mobile develops next-generation vehicle-to-everything (V2X) collision prevention solutions and smart automotive systems to enhance road safety and situational awareness for all road users in urban mobility environments. By leveraging cutting-edge artificial intelligence (AI) technology, advanced analytics, and existing cellular networks, Eye-Net’s innovative solution suite delivers real-time pre-collision alerts to all road users via smartphones and other smart devices within vehicles.

For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, visit www.foresightauto.com, follow @ForesightAuto1 on X, or join Foresight Automotive on LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, Foresight is using forward-looking statements in this press release when it discusses the proposed terms of the non-binding term sheet and its potential closing, its belief that the investment will provide Foresight with substantial financial strength to support ongoing operations, technology development, and commercialization of next-generation perception solutions, the benefits and advantages of Foresight’s and VisionWave’s technologies and Foresight’s solutions, Foresight’s business strategy, the potential signing of the definitive agreement and meeting the various closing conditions. Because such statements deal with future events and are based on Foresight’s current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of Foresight could differ materially from those described in or implied by the statements in this press release.

These forward-looking statements are made solely by Foresight and do not constitute statements or projections of VisionWave Holdings, Inc. VisionWave undertakes no obligation to update or revise any information contained in this press release.

The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in Foresight’s annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the Securities and Exchange Commission (“SEC”) on March 25, 2026, and in any subsequent filings with the SEC. Except as otherwise required by law, Foresight undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Foresight is not responsible for the content of third party websites.

Investor Relations Contact:

Miri Segal-Scharia
CEO
MS-IR LLC
[email protected]